Dow Down0.22% Nasdaq Up0.14%

GeneNews Limited (GEN.TO)

1.24 0.00(0.00%) Aug 22, 1:38PM EDT
ProfileGet Profile for:
GeneNews Limited
445 Apple Creek Boulevard
Suite 220
Markham, ON L3R 9X7
Canada - Map
Phone: 905-739-2030
Fax: 905-739-2031

Index Membership:N/A
Industry:Medical Laboratories & Research
Full Time Employees:N/A

Business Summary 

GeneNews Limited, a molecular diagnostics company, focuses on the development and application of functional genomics to enable early diagnosis and personalized health management based on disease specific biomarkers. Its principal platform technology, the Sentinel Principle, detects and stages various diseases or medical conditions from a blood sample. The company is applying the Sentinel Principle in the areas of cancer, arthritis, cardiovascular diseases, and neurological disorders. Its lead product includes ColonSentry, a blood-based molecular test to aid physicians in determining an individual’s risk of having colorectal cancer. The company was formerly known as ChondroGene Limited and changed its name to GeneNews Limited in October 2006. GeneNews Limited was founded in 1998 and is headquartered in Markham, Canada.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on GeneNews Limited

Key Executives 
Mr. James R. Howard-Tripp ,
Exec. Chairman, Member of Compensation & HR Committee and Member of Strategy Committee
Ms. Leslie Auld MBA, CPA, CA,
Chief Financial Officer, Treasurer, Director and Member of Strategy Committee
Mr. Karl Wassmann ,
Exec. VP of US Corp. Devel.
Dr. Choong-Chin Liew Ph.D.,
Co-Founder, Chief Scientist and Chairman of Scientific Advisory Board
Mr. David Suria ,
Sr. Scientist
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.
View Insiders